Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Flaskworks logo — Developing closed system cell culture devices for clinical m...

Flaskworks

Developing closed system cell culture devices for clinical manufacturing of cellular therapies.

Founded 2016 United States Boston, United States 5 employees Grant Biotechnology, Health Care +3

General Information

Company Name Flaskworks
Founded Year 2016
Location United States Boston, United States
Employees 5
Industries Biotechnology, Health Care, Life Sciences +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Flaskworks. To contact Flaskworks, visit flaskworks.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Flaskworks

Flaskworks LLC is a fully owned subsidiary of Northwest Biotherapeutics, Inc, a clinical stage biotechnology company focused on the development of personalized cancer vaccines. Flaskworks is developing closed system cell culture devices for clinical manufacturing of cellular therapies. Our technology will improve the manufacture of immuno-therapeutics and dendritic cell-based vaccines.

No funding data available for Flaskworks yet.

Flaskworks Alternatives & Competitors

Flaskworks vs
Lineage Cell Therapeutics
Lineage Cell Therapeutics United States

A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

Post-IPO Equity
33 employees
Biopharma, Biotechnology
Flaskworks vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Flaskworks vs
Northwest Biotherapeutics
Northwest Biotherapeutics United States

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering,...

Post-IPO Debt
16 employees
Biotechnology, Health Care

FAQ About Flaskworks

Developing closed system cell culture devices for clinical manufacturing of cellular therapies.
Flaskworks was founded in 2016.
Flaskworks is headquartered in Boston, United States.
Flaskworks operates in Biotechnology, Health Care, Life Sciences, Manufacturing and Pharmaceutical.
Flaskworks has approximately 5 employees.
Top alternatives and competitors to Flaskworks include Lineage Cell Therapeutics, Prescient Therapeutics, Northwest Biotherapeutics, Trillium Therapeutics Inc., Waisman Biomanufacturing. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Flaskworks and Lineage Cell Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Flaskworks, https://bouncewatch.com/company/flaskworks, updated 16 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes